Capricor Therapeutics (CAPR) Current Assets (2016 - 2025)
Historic Current Assets for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to $101.0 million.
- Capricor Therapeutics' Current Assets rose 1762.73% to $101.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.0 million, marking a year-over-year increase of 1762.73%. This contributed to the annual value of $163.4 million for FY2024, which is 22127.37% up from last year.
- As of Q3 2025, Capricor Therapeutics' Current Assets stood at $101.0 million, which was up 1762.73% from $124.1 million recorded in Q2 2025.
- Over the past 5 years, Capricor Therapeutics' Current Assets peaked at $163.4 million during Q4 2024, and registered a low of $29.5 million during Q3 2023.
- Over the past 5 years, Capricor Therapeutics' median Current Assets value was $46.6 million (recorded in 2023), while the average stood at $64.2 million.
- Per our database at Business Quant, Capricor Therapeutics' Current Assets plummeted by 3784.32% in 2023 and then surged by 30472.67% in 2025.
- Capricor Therapeutics' Current Assets (Quarter) stood at $36.4 million in 2021, then rose by 17.71% to $42.9 million in 2022, then increased by 18.58% to $50.9 million in 2023, then soared by 221.27% to $163.4 million in 2024, then plummeted by 38.21% to $101.0 million in 2025.
- Its Current Assets was $101.0 million in Q3 2025, compared to $124.1 million in Q2 2025 and $146.3 million in Q1 2025.